Regulation of type II transforming-growth-factor-β receptors by protein kinase C ι

TGF-beta (transforming growth factor-beta) is implicated in the pathogenesis of diabetic nephropathy. We previously demonstrated that up-regulation of type II TGF-beta receptor (TbetaRII) induced by high glucose might contribute to distal tubular hypertrophy [Yang, Guh,Yang, Lai, Tsai, Hung, Chang and Chuang (1998) J. Am.. Soc. Nephrol. 9, 182-193]. We have elucidated the mechanism by using cultured Madin-Darby canine kidney cells. Enhancer assay and electrophoretic-mobility-shift assay were used to estimate the involvement of transcription factors. Western blotting and an in vitro kinase assay were used to evaluate the level and activity of protein kinase. We showed that glucose (100-900 mg/ dl) induced an increase in mRNA level and promoter activity of TbetaRII (note: 'mg/dl' are the units commonly used in diabetes studies). The promoter region - 209 to - 177 appeared to contribute to positive transactivation of TbetaRII promoter by comparing five TbetaRII-promoter-CAT (chloramphenicol acetyltransferase) plasmids. Moreover, the transcription factor AP- I (activator protein 1) was significantly activated and specifically binds to TbetaRII promoter ( - 209 to - 177). More importantly, we found that atypical PKC t might be pivotal for high glucose-induced increase in both AP-1 binding and TbetaRII promoter activity. First, high glucose induced cytosolic translocation, activation and autophosphorylation of PKC i. Secondly, antisense PKC i expression plasmids attenuated high-glucose-induced increase in AP-1 binding and TbetaRII promoter activity; moreover, sense PKC i expression plasmids enhanced these instead. Finally, we showed that antisense PKC t expression plasmids might partly attenuate a high-glucose/TGF-betal-induced increase in fibronectin. We conclude that PKC i might mediate high glucose-induced increase in TbetaRII promoter activity. In addition, antisense PKC t expression plasmid effectively Suppressed up-regulation of TbetaRII and fibronectin in hyperglycaemic distaltubule cells.